https://patholines.org/index.php?action=history&feed=atom&title=Irradiated_blood 2026-08-20T16:17:11Z Revision history for this page on the wiki MediaWiki 1.44.2 https://patholines.org/index.php?title=Irradiated_blood&diff=2697&oldid=prev 2020-10-30T23:49:51Z

<p>Started</p> <p><b>New page</b></p><div>{{Top<br /> |author1=[[User:Mikael Häggström|Mikael Häggström]]<br /> |author2=<br /> }}<br /> Cellular blood components for the following patients/situations should be irradiated to reduce the risk of transfusion associated graft-versus-host disease:&lt;ref&gt;{{cite web|url=http://psons.org/wp-content/uploads/2015/03/21a-PSBC-Blood-Components-Special-Attributes-Indications-2015.pdf|title=Puget Sound Blood Center - Indications for Special Attributes - Blood Components to Minimize CMV Transmission|accessdate=2020-10-30}}&lt;/ref&gt;<br /> *Hematopoietic stem cell (HSC) transplant recipients<br /> *HSC transplant candidates under some circumstances<br /> *HSC donors if allogeneic transfusion must be given prior to completing the harvest<br /> *Congenital T-cell immune deficiency<br /> *Intrauterine or neonatal exchange transfusion<br /> *Transfusion from family members or HLA-selected donors<br /> *Patients who have had fludarabine chemotherapy<br /> *Hodgkin’s disease<br /> *Leukemia<br /> *Lymphoproliferative disorders<br /> *Granulocyte transfusion<br /> *Neonates<br /> *Aggressive chemotherapy, radiotherapy or T-cell immunosuppression<br /> {{Bottom}}</div>

Mikael Häggström